The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma
Abstract
A large number of immunohistochemical markers that can facilitate the distinction between epithelioid pleural mesotheliomas and pulmonary peripheral adenocarcinomas have recently become available. The aim of this study is to compare the value of these new markers with others that are already commonly used for this purpose and to determine which are, at present, the best for discriminating between these malignancies. Sixty epithelioid mesotheliomas and 50 lung adenocarcinomas were investigated for expression of the following markers: calretinin, cytokeratin 5/6, WT1, thrombomodulin, mesothelin, CD44S, HBME-1, N-cadherin, E-cadherin, MOC-31, thyroid transcription factor-1 (TTF-1), BG-8 (Lewisy), carcinoembryonic antigen (CEA), Ber-EP4, B72.3 (TAG-72), leu-M1 (CD15), CA19-9, epithelial membrane antigen (EMA), and vimentin. All (100%) of the mesotheliomas reacted for calretinin, cytokeratin 5/6, and mesothelin, 93% for WT1, 93% for EMA, 85% for HBME-1, 77% for thrombomodulin; 73% for CD44S, 73% for N-cadherin, 55% for vimentin, 40% for E-cadherin, 18% for Ber-EP4, 8% for MOC-31, 7% for BG-8, and none for CEA, B72.3, leu-M1, TTF-1, or CA19-9. Of the adenocarcinomas, 100% were positive for MOC-31, Ber-EP4, and EMA, 96% for BG-8, 88% for CEA, 88% for E-cadherin, 84% for B72.3, 74% for TTF-1, 72% for leu-M1, 68% for HBME-1, 48% for CD44S, 48% for CA19-9, 38% for mesothelin, 38% for vimentin, 30% for N-cadherin, 14% for thrombomodulin, 8% for calretinin, 2% for cytokeratin 5/6, and none for WT1. After analyzing the results, it is concluded that calretinin, cytokeratin 5/6, and WT1 are the best positive markers for differentiating epithelioid malignant mesothelioma from pulmonary adenocarcinoma. The best discriminators among the antibodies considered to be negative markers for mesothelioma are CEA, MOC-31, Ber-EP4, BG-8, and B72.3. A panel of four markers (two positive and two negative) selected based upon availability and which ones yield good staining results in a given laboratory is recommended. Because of their specificity and sensitivity for mesotheliomas, the best combination appears to be calretinin and cytokeratin 5/6 (or WT1) for the positive markers and CEA and MOC-31 (or B72.3, Ber-EP4, or BG-8) for the negative markers. An extensive and detailed review of the literature is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chang, K., & Pastan, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 745
Argani, P., Iacobuzio–Donahue, C. A., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E. M., Yeo, C. J., et al. (2001) · PubMed · Cited by 574
Calretinin: A Novel Immunocytochemical Marker for Mesothelioma
Doglioni, C., Dei, A. P., Laurino, L., Iuzzolino, P., Chiarelli, C., Celio, M. R., & Viale, G. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199609000-00001 · Cited by 427
TTF-1 Expression in Pulmonary Adenocarcinomas
Yatabe, Y., Mitsudomi, T., & Takahashi, T. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200206000-00010 · Cited by 380
Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.
Latza, U., Niedobitek, G., Schwarting, R., Nekarda, H., & Stein, H. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.3.213 · Cited by 376
Kaufmann, O., Fietze, E., Mengs, J., & Dietel, M. (2001) · American Journal of Clinical Pathology · doi:10.1309/21tw-2ndg-jrk4-pfjx · Cited by 324
Chang, K., Pastan, I., & Willingham, M. C. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500308 · Cited by 271
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Chu, P. G., & Weiss, L. M. (2002) · Modern Pathology · doi:10.1038/modpathol.3880483 · Cited by 257
Thyroid Transcription Factor-1 is a Marker of Lung and Thyroid Carcinomas
Ordóñez, N. G. (2000) · Advances in Anatomic Pathology · doi:10.1097/00125480-200007020-00007 · Cited by 245
Self-citationCorson, J. M., & Pinkus, G. S. (1982) · PubMed · Cited by 222
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0021 · Cited by 735
Ettinger, D. S., Akerley, W., Bepler, G., Blum, M. G., Chang, A., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Demmy, T. L., Ganti, A. K. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0056 · Cited by 730
Mukhopadhyay, S., & Katzenstein, A.-L. A. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182036d05 · Cited by 314
Ordóñez, N. G. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.01.019 · Cited by 255
Self-citation
Metadata
- Authors
- Ordóñez, N. G.
- Venue
- The American Journal of Surgical Pathology
- Published
- 2003-08
- Volume
- 27
- Issue
- 8
- Pages
- 1031-1051
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2037954581
- Cited by
- 406
- References
- 34
- FWCI
- 24.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma. https://app.cochat.ai/papers/10.1097/00000478-200308000-00001
- The paper
- Ordóñez, N. G. (2003). The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma. The American Journal of Surgical Pathology. https://doi.org/10.1097/00000478-200308000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.